DENEUCARE
ActiveSummary
DENEUCARE has been active since 2002 and the Belgian Official Gazette contains no insolvency or warning signals. The 2024 annual accounts show equity of €1.3m and a net result of €98,460. Equity is growing by about 9% per year across the filed financial years. Its solvency ranks better than 43% of 19,744 sector peers (NACE 86, financial year 2024). The computed 12-month bankruptcy probability is 0.1% (very low).
Directors
Directors
1 director, no change since 2023
DENEU Stéphane
CurrentDirector (not named in the articles) · since 01-09-2023
Derived from published Gazette deeds. The KBO keeps the official list of office holders; we do not read it, so the two can differ.
See the directors and other office holders in the KBO →
Mandate history
1 person since 2023, 1 in office
- Board
- began earlier
| Name | Functions and periods |
|---|---|
| DENEU Stéphane |
|
Owners and capital
Capital and shareholders
Capital over the years
- 01-09-2023 Converted to unavailable equity